GSN and ovarian cancer: Abedini et al.[48] further demonstrated that gelsolin was highly expressed in chemoresistant ovarian cancer cells and cisplatin failed to abolish the intact gelsolin-FLIP-ITCH interaction, leading to the dysregulation of the downstream responses.